British Society for Antimicrobial Chemotherapy.Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis.Lancet1987; 1: 845–9.
6.
TroidleL., KligerA.S., Gorban–BrennanN., FikrigM., GoldenM., FinkelsteinF.O.Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci.Kidney Int1996; 50: 1368–72.
7.
Aminoglycoside Resistance Study Groups.The most frequent aminoglycoside resistance mechanisms — changes with time and geographic area: A reflection of aminoglycoside usage patterns?Clin Infect Dis1997; 24(Suppl 1): S46–62.
SheminD., MaazD., St PierreD., KahnS.I., ChazanJ.A.Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.Am J Kidney Dis1999; 34: 14–20.
10.
GucekA., BrenA.F., HergouthV., LindicJ.Cefazolin and netilmicin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1997; 13: 218–20.
11.
LaiM.N., KaoM.T., ChenC.C., CheungS.Y., ChungW.K.Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis.Perit Dial Int1997; 17: 87–9.